A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression.
The duration of treatment is 8 weeks.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
495
HAMD-17 total score at week 8. Tolerability.
CGI-I Scale score at week 8 and at least a 50% reduction in the HAMD-17 total score.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.